SCHEMBL7814130

SCHEMBL7814130

CC(C)(Oc1ccc(C2CCN(C(=O)c3ccncc3)CC2)cc1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.54
HSD11B1 P28845 1/20 0.51
KDM4E B2RXH2 1/20 0.48
RECQL P46063 1/20 0.48
EPHX2 P34913 1/20 0.47
PARP10 Q53GL7 1/20 0.47
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
BLM P54132 1/20 0.46
PPARA Q07869 1/20 0.46
F2R P25116 1/20 0.46
GAA P10253 2/20 0.44
TRPC6 Q9Y210 1/20 0.44
ALDH1A1 P00352 1/20 0.44
EGLN1 Q9GZT9 1/20 0.44
MAPK7 Q13164 2/20 0.43
SCD O00767 1/20 0.43
SCD5 Q86SK9 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7810069 0.91 HSD11B1 (0.59) LMNAHSD11B1PARP10CYP2C9TSHR
SCHEMBL7810206 0.88 HSD11B1 (0.54) LMNAHSD11B1PARP10CYP2C9TSHR
SCHEMBL7804429 0.88 HSD11B1 (0.66) LMNAHSD11B1PARP10GAAALDH1A1
SCHEMBL7810099 0.88 ALDH1A1 (0.52) LMNAHSD11B1EPHX2GAAALDH1A1
SCHEMBL7810110 0.88 HSD11B1 (0.51) HSD11B1PARP10TSHRPPARAGAA
SCHEMBL7814102 0.87 HSD11B1 (0.53) LMNAHSD11B1PARP10CYP2C9TSHR
SCHEMBL7817468 0.87 PPARA (0.57) LMNAHSD11B1PARP10CYP2C9TSHR
SCHEMBL7813621 0.87 HSD11B1 (0.53) LMNAHSD11B1PARP10CYP2C9TSHR
SCHEMBL7811341 0.87 PARP10 (0.64) LMNAHSD11B1KDM4EPARP10CYP2C9
SCHEMBL7817510 0.87 BCL9 (0.57) LMNAHSD11B1KDM4ERECQLPARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed